Skip to Content

Healtheuniverse Inc HLUN

Morningstar Rating
$0.00 0.00 (84.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HLUN is trading at a 240% premium.
Price
$0.00
Fair Value
$2.94
Uncertainty
Extreme
1-Star Price
$7.12
5-Star Price
Economic Moat
Xhvq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HLUN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$1,884.40
Volume/Avg
21,300 / 11,300

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Healtheuniverse Inc is engaged in the development and commercialization of biopharmaceutical and biomedical products. The company develops and provides early stage project initiation, financing, product commercialization and development of patented and proprietary biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
Website

Valuation

Metric
HLUN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
HLUN
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
HLUN
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRGnvtqhncqcDmx$605.7 Bil
VRTX
Vertex Pharmaceuticals IncPbkznyzvwJrskw$116.3 Bil
REGN
Regeneron Pharmaceuticals IncMlfnllmkCrjlty$108.5 Bil
MRNA
Moderna IncBknlhftjKybv$62.9 Bil
BNTX
BioNTech SE ADRTqvqttpsThmr$23.9 Bil
ARGX
argenx SE ADRMqnjggjryDchbh$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncMrcjpchQppbtkw$18.9 Bil
BMRN
Biomarin Pharmaceutical IncKcsgywydXysnh$14.3 Bil
INCY
Incyte CorpFbjxzbkqZsyhnp$12.9 Bil
UTHR
United Therapeutics CorpFlnjmtwmTrsf$12.1 Bil

Sponsor Center